Clinical Trial Update: Sequential Icotinib Plus Chemotherapy Versus Icotinib Alone as First-line Treatment in Stage IIIB/IV Lung Adenocarcinoma [Phase 4]

View source ↗

Summary

A Phase 4 trial is evaluating whether adding sequential chemotherapy to icotinib improves first-line treatment outcomes for stage IIIB/IV EGFR-positive non-smal…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Adenocarcinoma
• Non-small Cell Lung Cancer

Drugs mentioned

• icotinib (icotinib)

Snippet

Sponsor: Betta Pharmaceuticals Co., Ltd. | Conditions: EGFR Positive Non-small Cell Lung Cancer, Adenocarcinoma | Phase 4 | Status: UNKNOWN